Millennium Pharmaceuticals

                   

Japan goes on buying spree, shrugging off '80s bubble

business-standard.com     Aug 27, 2008          

Japanese companies are increasing overseas acquisitions, using their cash-hoards to snap up assets beaten down by the global credit crisis and economic slowdown. The value of foreign purchases by Japanese companies this...                    

comments

Helicos appoints three in bid to boost R & D (at bizjournals.com)

yahoo.com     Aug 27, 2008          

has made three executive appointments in a bid to accelerate its research and development efforts. The Cambridge, Mass.-based company (Nasdaq: HLCS) said it has named Bill Efcavitch as its new chief technology officer....                    

comments

Bristol-Myers Gambles On Kosan (at Forbes.com)

yahoo.com     Aug 27, 2008          

Bristol-Myers Squibb is trying to regain its throne as the leading provider of cancer treatments now that its drug Taxol has a slew of generic copycats eating into its sales. But it may be trying too hard: an takeover...                    

comments

Market Spotlight: Biotech acquisition trends (AP)

yahoo.com     Aug 27, 2008          

With research and development pipelines lagging and patent expirations on many key drugs looming, large pharmaceutical and biotech companies are increasingly looking to biotechnology acquisitions as a way to bring new...                    

comments

Biotech buyout action likely to continue

ibtimes.com     Aug 20, 2008   4 related          

NEW YORK - A buyout bull's-eye will likely remain on biotechnology companies over the next few years as major pharmaceutical companies continue taking advantage of a weak dollar and a surplus of cash to buy pipeline additions....                    

comments

Research and Markets: Essential Chartbook of International Pharmaceutical Prices for 2008 from...

pharmiweb.co.uk     Aug 20, 2008   1 related          

More News related to Press Releases ) has announced the addition of Decision Resources, Inc.'s new report "2008 Chartbook of International Pharmaceutical Prices" to their offering. To best determine pricing, pharmaceutical...                    

comments

                   

Genentech Asks Roche to Pay Up (at Motley Fool)

yahoo.com     Aug 14, 2008          

In one of the more friendly spurnings of a buyout offer in recent months, Genentech (NYSE: DNA) yesterday called Roche's $89-per-share buyout offer too low, and very nicely implied that Roche should up its bid. Three weeks ago,...                    

comments

                   

Biotech battle brewing? Genentech nixes Roche's takeover bid

pharmiweb.co.uk     Aug 14, 2008   120 related          

18:45 PDT -- But the committee also invited Roche - which already owns a majority share of Genentech but now wants to own the whole thing - to make a richer offer, dampening speculation that Genentech will try to resist the...                    

comments

                   

Genentech To Roche: You're Cheap

forbes.com     Aug 13, 2008   9 related          

partner ImClone Systems (nasdaq: A three-member special committee assembled by Genentech’s board of directors said the deal “substantially undervalues” the company. But the committee said it “would consider a proposal that...                    

comments

Weak Dollar Motivates CSL

forbes.com     Aug 13, 2008   27 related          

Vivian Wai-yin Kwok and Lisa LaMotta 08.13.08, 4:50 PM ET The weakened dollar has pushed one more foreign company to assets buying assets in the U.S., with Australia's CSL jumping on the opportunity to purchase Talecris...                    

comments

1 2 3 4 5 next »